核内Pirin作为关键炎症促进因子促进肝细胞癌进展
本研究通过RNA干扰、基因敲除和药物抑制在肝细胞癌细胞系及多种小鼠模型中探究氧化应激感受蛋白Pirin(PIR)在肝细胞癌进展中的炎症介导作用,揭示核内PIR放大炎症反应的正反馈轴,并发现N-乙酰半胱氨酸或PIR抑制剂可抑制PIR的氧化还原介导核转位、减少小鼠肝细胞癌促进。
要点
- 核内PIR通过增强RELA转录放大炎症反应,促进肝炎和肝细胞癌进展。
- 肝实质细胞产生自分泌细胞因子支持自身生长和恶性表型。
- N-乙酰半胱氨酸或PIR抑制剂可抑制PIR核转位并减少小鼠肝细胞癌促进。
核心结论
- 本研究阐明一种新的氧化还原依赖性调节机制控制PIR核定位及其促进肝脏炎症和肝细胞癌进展的作用。
- 研究结果强调细胞氧化还原状态在调节PIR活性中的重要性,并突出靶向该通路以抗氧化剂减轻肝细胞癌进展的潜力。
研究设计与样本
- 在肝细胞癌细胞系和多种小鼠模型中通过RNA干扰、基因敲除和药物抑制研究PIR在肝细胞癌肿瘤发生中的作用。
- 使用转录组学、定量逆转录PCR、蛋白质印迹、免疫荧光染色和免疫组织化学分析阐明分子细节。
主要发现
- 研究揭示一种新的氧化还原依赖性机制调控PIR核穿梭,促进肝脏炎症和肝细胞癌进展。
- 鉴定出一个正反馈轴,其中核内PIR放大炎症反应,导致肝炎和肝细胞癌进展。
- 该环路中的细胞因子受PIR增强的v-rel网状内皮增生症病毒癌基因同源物A(RELA)转录调控,促进PIR核转位、增加促炎细胞因子水平并破坏氧化还原平衡。
- 证实肝实质细胞产生自分泌细胞因子支持其生长和恶性程度。
- PIR的氧化还原介导核转位可被N-乙酰半胱氨酸或PIR抑制剂抑制,减少小鼠肝细胞癌促进。
临床怎么用
- 作者认为靶向该通路以抗氧化剂可能减轻肝细胞癌进展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic inflammation and elevated reactive oxygen species are key contributors to hepatocellular carcinoma (HCC) progression. OBJECTIVE: This study aims to investigate the role of the oxidative stress sensor protein Pirin (PIR) as a critical mediator of inflammation in HCC progression. DESIGN: We investigated PIR's role in HCC tumourigenesis through RNA interference, genetic knockout and pharmaceutical inhibition in HCC cell lines and various mouse models. Furthermore, we used transcriptomics, quantitative reverse transcription PCR, western blot, immunofluorescence staining and immunohistochemistry analysis to elucidate the molecular details. RESULTS: This study reveals a novel redox-dependent mechanism governing PIR's nuclear shuttling, contributing to liver inflammation and HCC progression. We identified a positive feedback axis where nuclear PIR amplifies inflammatory responses, leading to hepatitis and HCC advancement. Cytokines in this loop are regulated by PIR-enhanced v-rel reticuloendotheliosis viral oncogene homolog A (RELA) transcription, promoting PIR's nuclear translocation, increasing proinflammatory cytokine levels, and disrupting redox balance. We confirmed that liver parenchymal cells produce autocrine cytokines supporting their growth and malignancy. Notably, PIR's redox-mediated nuclear shift can be inhibited by N-acetyl cysteine or PIR inhibitors, reducing HCC promotion in mice. CONCLUSION: We elucidate a novel redox-dependent regulatory mechanism governing the nuclear localisation of PIR and its role in promoting liver inflammation and HCC progression. Our findings underscore the significance of cellular redox status in regulating PIR's activity and highlight the potential of targeting this pathway with antioxidants to mitigate HCC progression.
引用
- Ma H, Cao T, Zhang F, et al. Nuclear Pirin promotes HCC by acting as a key inflammation-facilitating factor. Gut. 2026. PMID: 40579121. doi:10.1136/gutjnl-2024-334087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。